Cargando…

Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report

BACKGROUND: Sweet syndrome (SS) is characterized by sudden appearance of multiple, painful erythematous, papular-nodular skin lesions accompanied by a fever and myalgia. SS resembles Visphota (Bullous eruption disorders) in Ayurveda. SS is a scarcerare skin condition, and Ayurvedic management of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Ashok Kumar, S, Krishna Rao, Kar, Bikash Ranjan, Kar, Sarbeswar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227415/
https://www.ncbi.nlm.nih.gov/pubmed/37253314
http://dx.doi.org/10.1016/j.jaim.2023.100709
_version_ 1785050766674755584
author Panda, Ashok Kumar
S, Krishna Rao
Kar, Bikash Ranjan
Kar, Sarbeswar
author_facet Panda, Ashok Kumar
S, Krishna Rao
Kar, Bikash Ranjan
Kar, Sarbeswar
author_sort Panda, Ashok Kumar
collection PubMed
description BACKGROUND: Sweet syndrome (SS) is characterized by sudden appearance of multiple, painful erythematous, papular-nodular skin lesions accompanied by a fever and myalgia. SS resembles Visphota (Bullous eruption disorders) in Ayurveda. SS is a scarcerare skin condition, and Ayurvedic management of this condition is not reported. Therefore, this case report is prepared after taking informed consent from the patient. CASE PRESENTATION: A 34-year-old male patient presented with a complaint of the appearance of multiple blisters over the upper and lower extremities, forehead, and chest with mild fever, congestion of the eye, joint pain, and muscular stiffness for the last two weeks. He has been on oral prednisolone for ten weeks by a dermatologist. The patient has no history of taking drugs in the previous four months before the onset of the skin lesions. The patient was prescribed Nagaradi Kasya (Amrttam Kasaya), Siddha Makardwaja (Plain), Kaisara Guggulu (KG), Ashwagandha ghana vati, and Avipatikar Churna in recommended dose for two weeks. Fifty percentage lesions disappear along systemic symptoms within seven days and complete remission of lesions in fifteen days. The medication was stopped after fifteen days and observed for one year. There is a significant reduction of inflammatory markers like-erythrocyte sedimentation rate (ESR), Total Leucocyte Count (TLC), and C Reactive protein (CRP) after the treatment compared to the baseline also. CONCLUSION: Ayurvedic modalities may be a better treatment option in rare skin conditions like sweet syndrome, where corticosteroid usage failed to improve. More evidence of the usefulness of the Ayurvedic therapeutic approach must be gathered.
format Online
Article
Text
id pubmed-10227415
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102274152023-05-31 Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report Panda, Ashok Kumar S, Krishna Rao Kar, Bikash Ranjan Kar, Sarbeswar J Ayurveda Integr Med Case Report BACKGROUND: Sweet syndrome (SS) is characterized by sudden appearance of multiple, painful erythematous, papular-nodular skin lesions accompanied by a fever and myalgia. SS resembles Visphota (Bullous eruption disorders) in Ayurveda. SS is a scarcerare skin condition, and Ayurvedic management of this condition is not reported. Therefore, this case report is prepared after taking informed consent from the patient. CASE PRESENTATION: A 34-year-old male patient presented with a complaint of the appearance of multiple blisters over the upper and lower extremities, forehead, and chest with mild fever, congestion of the eye, joint pain, and muscular stiffness for the last two weeks. He has been on oral prednisolone for ten weeks by a dermatologist. The patient has no history of taking drugs in the previous four months before the onset of the skin lesions. The patient was prescribed Nagaradi Kasya (Amrttam Kasaya), Siddha Makardwaja (Plain), Kaisara Guggulu (KG), Ashwagandha ghana vati, and Avipatikar Churna in recommended dose for two weeks. Fifty percentage lesions disappear along systemic symptoms within seven days and complete remission of lesions in fifteen days. The medication was stopped after fifteen days and observed for one year. There is a significant reduction of inflammatory markers like-erythrocyte sedimentation rate (ESR), Total Leucocyte Count (TLC), and C Reactive protein (CRP) after the treatment compared to the baseline also. CONCLUSION: Ayurvedic modalities may be a better treatment option in rare skin conditions like sweet syndrome, where corticosteroid usage failed to improve. More evidence of the usefulness of the Ayurvedic therapeutic approach must be gathered. Elsevier 2023 2023-05-28 /pmc/articles/PMC10227415/ /pubmed/37253314 http://dx.doi.org/10.1016/j.jaim.2023.100709 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Panda, Ashok Kumar
S, Krishna Rao
Kar, Bikash Ranjan
Kar, Sarbeswar
Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report
title Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report
title_full Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report
title_fullStr Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report
title_full_unstemmed Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report
title_short Sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: A case report
title_sort sweet syndrome unresponsive to corticosteroid therapy managed with ayurveda medication: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227415/
https://www.ncbi.nlm.nih.gov/pubmed/37253314
http://dx.doi.org/10.1016/j.jaim.2023.100709
work_keys_str_mv AT pandaashokkumar sweetsyndromeunresponsivetocorticosteroidtherapymanagedwithayurvedamedicationacasereport
AT skrishnarao sweetsyndromeunresponsivetocorticosteroidtherapymanagedwithayurvedamedicationacasereport
AT karbikashranjan sweetsyndromeunresponsivetocorticosteroidtherapymanagedwithayurvedamedicationacasereport
AT karsarbeswar sweetsyndromeunresponsivetocorticosteroidtherapymanagedwithayurvedamedicationacasereport